Ophthalmic Implant Surface Stiffness for PCO Cell Migration Control
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for preventing posterior capsule opacification (PCO) after cataract surgery, such as square-edge IOL designs and pharmacological treatments, are not highly effective, leading to the need for invasive Nd:YAG laser capsulotomy, which can have side effects.
Innovation Solution
An ophthalmic implant with varying surface stiffness, featuring regions with different Young's moduli to control cell migration by creating mechanical barriers or guiding cells to specific areas, thereby reducing the risk of PCO without the need for drugs or invasive procedures.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If square-edge IOL design is used, then cell migration is partially inhibited, but PCO prevention effectiveness remains insufficient
Solution Approach 1:
The implant incorporates surface regions with different stiffness characteristics - a first surface region with first stiffness and a second surface region with second stiffness. This local differentiation allows specific zones to perform specialized functions: one region inhibits cell migration while another permits controlled cell interaction, thereby enhancing overall PCO prevention effectiveness without requiring complex multi-component structures.
Solution Approach 2:
The patent varies the stiffness parameter across different surface regions of the implant. By controlling the stiffness characteristic in different zones, the implant creates mechanical barriers in specific areas to prevent cell migration while maintaining appropriate flexibility in other regions, thus improving PCO prevention without increasing structural complexity.
2Reliability
If pharmacological treatments are administered, then cell proliferation is reduced, but drug release variability over time occurs
Solution Approach 1:
The patent replaces pharmacological interventions with a mechanical approach - using stiffness-modulated surface regions to physically inhibit cell migration. This mechanical barrier provides consistent, time-independent control over cell behavior, eliminating the temporal variability inherent in drug release mechanisms while maintaining reliable cell migration inhibition.
3Reliability
If Nd:YAG laser capsulotomy is performed, then PCO is treated effectively, but invasive procedures and side effects are introduced
Solution Approach 1:
The implant provides preliminary action by establishing mechanical barriers at the time of implantation that proactively prevent cell migration before PCO can develop. This preventive approach eliminates the need for subsequent invasive laser procedures and their associated side effects, while maintaining effective PCO control throughout the postoperative period.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The implant effectively inhibits or directs cell migration, reducing the risk of PCO and associated visual impairments, eliminating the need for laser capsulotomy and drug release variability over time.
Implementation Method 1
The base body (12) comprises at least a first surface region (14a) with a first Young's modulus (Ea) and a second surface region (14b) with a second Young's modulus (Eb), wherein the first and second Young's moduli (Ea, Eb) differ from one another
Data Source
Figure 1~3
Figure 4~6
Figure 7~9
AI summary
The invention relates to an opthalmological implant (10) comprising a main body (12) having at least one first surface region (14a) with a first Young's modulus Ea) and a second surface region (14b) with a second Young's modulus (Eb), the first and the second Young's modulus (Ea, Eb) differing from one another.